PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $31,000 | -11.4% | 36,270 | 0.0% | 0.00% | – |
| Q2 2019 | $35,000 | -75.9% | 36,270 | -68.4% | 0.00% | – |
| Q1 2019 | $145,000 | -83.4% | 114,720 | -57.4% | 0.00% | – |
| Q4 2018 | $871,000 | +480.7% | 268,990 | +331.6% | 0.00% | – |
| Q3 2018 | $150,000 | -13.8% | 62,318 | -0.0% | 0.00% | – |
| Q2 2018 | $174,000 | +107.1% | 62,319 | +252.8% | 0.00% | – |
| Q1 2018 | $84,000 | +31.2% | 17,666 | +61.4% | 0.00% | – |
| Q4 2017 | $64,000 | +28.0% | 10,946 | -54.1% | 0.00% | – |
| Q3 2017 | $50,000 | -55.4% | 23,833 | 0.0% | 0.00% | – |
| Q2 2017 | $112,000 | -59.0% | 23,833 | -31.8% | 0.00% | – |
| Q1 2017 | $273,000 | -25.2% | 34,964 | +17.3% | 0.00% | – |
| Q4 2016 | $365,000 | +10.3% | 29,811 | +40.4% | 0.00% | – |
| Q3 2016 | $331,000 | +78.9% | 21,227 | +39.3% | 0.00% | – |
| Q2 2016 | $185,000 | – | 15,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 5,556,778 | $4,695,000 | 0.39% |
| GREAT POINT PARTNERS LLC | 3,500,000 | $2,958,000 | 0.27% |
| HARBOURVEST PARTNERS LLC | 440,627 | $372,000 | 0.16% |
| VHCP Management III, LLC | 221,267 | $187,000 | 0.12% |
| VHCP Management II, LLC | 130,733 | $110,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 184,955 | $156,000 | 0.02% |
| Bain Capital Public Equity Management II, LLC | 202,050 | $171,000 | 0.02% |
| Kazazian Asset Management, LLC | 12,769 | $11,000 | 0.02% |
| Rock Springs Capital Management LP | 400,000 | $338,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 138,056 | $117,000 | 0.01% |